MS
KRRO icon

Mizuho Securities’s Korro Bio KRRO Stock Holding History

Mizuho Securities’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-9,421
Closed -$9.05M – 177
2020
Q3 		$9.05M Sell
9,421
-36
-0.4% -$38.6K 1.63% 3
2020
Q2 		$8.42M Hold
9,457
– – 2.37% 2
2020
Q1 		$8.42M Hold
9,457
– – 15.09% 1
2019
Q4 		$8.29M Buy
+9,457
New +$7.36M 4.4% 7

Other funds holding KRRO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MICM
Matthews International Capital Management San Francisco, California $292M AUM 75.01% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Mizuho Securities's KRRO Position: Q4 2020 in Review

Mizuho Securities sold out of Korro Bio (KRRO) in Q4 2020, closing a stake of 9,421 shares — an estimated $9.05M sold.

Mizuho Securities first reported a position in KRRO in Q4 2019 and held it in 4 quarters. The position peaked at $9.05M in Q3 2020. 100 funds tracked by Wall St. Rank hold KRRO as of Q4 2020.

  • Mizuho Securities reported no remaining Korro Bio position as of Q4 2020 after selling out during the quarter.
  • Mizuho Securities sold 9,421 Korro Bio shares in Q4 2020, an estimated $9.05M.
  • Mizuho Securities first reported a position in Korro Bio in Q4 2019 and held it in 4 quarters.
  • Mizuho Securities's Korro Bio position peaked at $9.05M in Q3 2020.
  • 100 funds tracked by Wall St. Rank held Korro Bio as of Q4 2020.

Based on Mizuho Securities's 13F filing for Q4 2020, filed 12 Feb 2021.